Cite
MLA Citation
Alexa B. Schrock et al.. “RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer.” Oncologist, vol. 26, 2021, pp. 469–475. http://access.bl.uk/ark:/81055/vdc_100132239127.0x000029